INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Mankind Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543904	ISIN Demat INE634S01028	Book Value 334.17	NSE Symbol MANKIND	Dividend Yield (%) 0	Market Cap (₹ Cr.) 97,009.59	P/E 50.17	EPS 46.87	Face Value 1

Particulars (₹ Cr)	Dec 2024	Sep 2024	Jun 2024	Mar 2024

Gross Sales/Income from operations	2396.57	2529.74	2403.26	1996.55
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,396.57	2,529.74	2,403.26	1,996.55
Other Operating Income	0.00	0.00	0.00	0.00
Total Income from operations (net)	2,396.57	2,529.74	2,403.26	1,996.55
Total Expenses	1,742.67	1,863.13	1,914.46	1,563.63
Cost of Sales	659.40	703.37	686.49	559.37
Employee Cost	521.79	525.86	522.10	486.15
Depreciation, amortization and depletion expense	87.03	85.42	83.40	82.25
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	474.45	548.48	622.47	435.86
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	653.90	666.61	488.80	432.92
Other Income	69.82	105.76	94.83	83.85
Profit from ordinary activities before finance costs and exceptional items	723.72	772.37	583.63	516.77
Finance Costs	199.47	1.92	6.26	4.03
Profit from ordinary activities after finance costs but before exceptional items	524.25	770.45	577.37	512.74
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	524.25	770.45	577.37	512.74
Total Tax	107.87	168.01	93.12	82.15
Net profit from Ordinary Activities After Tax	416.38	602.44	484.25	430.59
Profit / (Loss) from Discontinued Operations	0.00	31.99	29.24	23.58
Net profit from Ordinary Activities/Discontinued Operations After Tax	416.38	634.43	513.49	454.17
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	416.38	634.43	513.49	454.17
Other Comprehensive Income	9.41	0.17	-1.34	-7.37
Total Comprehensive Income	425.79	634.60	512.15	446.80
Equity	40.06	40.06	40.06	40.06
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	10.35	15.84	12.82	11.34
EPS before Exceptional/Extraordinary items-Diluted	10.33	15.81	12.80	11.32
EPS after Exceptional/Extraordinary items-Basic	10.35	15.84	12.82	11.34
EPS after Exceptional/Extraordinary items-Diluted	10.33	15.81	12.80	11.32
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00